RETHYMIC
NDC 72359-001, allogenic thymocyte-depleted thymus tissue-agdc, implant, from Sumitomo Pharma America, Inc..
- Product NDC
- 72359-001
- Status
- Listed
- Labeler
- Sumitomo Pharma America, Inc.
- Dosage form
- IMPLANT
- Route
- INTRAMUSCULAR
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA125685
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/72359-001 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ALLOGENEIC THYMOCYTE-DEPLETED THYMUS TISSUE-AGDC22000 mm/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 72359-001-01 | 72359000101 | 11 CONTAINER in 1 BOX (72359-001-01) / 4 IMPLANT in 1 CONTAINER (72359-001-02) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/e0022c28-8cda-4f1e-bcf1-1f440d37ec4a
Use it
Look up 72359-001 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/72359-001 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 72359-001. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.